Publication|Articles|April 2, 2026
Supplements and Featured Publications
- A Novel, Double-stranded Small Interfering RNA Therapeutic Designed to Silence Apolipoprotein C-III in Familial Chylomicronemia Syndrome
A Novel, Double-stranded Small Interfering RNA Therapeutic Designed to Silence Apolipoprotein C-III in Familial Chylomicronemia Syndrome
Advertisement
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs
2
5 Ongoing Clinical Trials in Myeloproliferative Neoplasms
3
Fourteen Years of HIV PrEP: How New Innovations Build on Decades of Progress in HIV
4
Walcker Named President of Cardinal’s The Specialty Alliance, With Strengths in GI, Urology
5